LncRNA TUG1调控Th2/Th17细胞极化在支气管哮喘免疫病理中的作用及机制研究

基本信息
批准号:81771676
项目类别:面上项目
资助金额:56.00
负责人:陈正荣
学科分类:
依托单位:苏州大学
批准年份:2017
结题年份:2021
起止时间:2018-01-01 - 2021-12-31
项目状态: 已结题
项目参与者:季伟,徐利晓,顾文婧,李庆玲,陈嘉韡,孙赛男
关键词:
RNAlong29c3pTh细胞极化B7H3支气管哮喘microRNAnoncodingTUG1
结项摘要

The fountain of immunopathogenesis of asthma is based on Th2 and Th17 cell polarization. The mechanism of Th2 and Th17 cell polarization is still unclear and might be associated with LncRNA. LncRNA TUG1 is identified from children with asthma by differential lncRNA expression profile chips. Our previous study revealed that LncRNA TUG1 could enhance B7-H3 expression in mononuclear macrophage and induce Th2/Th17 polarization. B7-H3 plays vital role in Th2 and Th17 cell polarization and B7-H3 is also the direct target gene of miR-29c-3p. Over expression or Silent expression miR-29c-3p could down-regulated or up-regulated B7-H3 in mononuclear macrophage. There are combining sites between LncRNA TUG1 and miR-29c-3p using bioinformatics. Thus, we hypothesized that LncRNA TUG1 could regulate B7-H3 through miR-29c-3p which could induce Th2/Th17 polarization and play vital role in immunopathogenesis of asthma. Therefore, the specific objectives of this research are to clarify the mechanism of LncRNA TUG1 expression induced by allergen and to explore the role and mechanism of LncRNA TUG1 expression in mononuclear macrophage during regulating Th2/Th17 polarization based on experiments in vitro and vivo. In all, this study is to provide new targets for immunologic intervention of asthma.

Th2/Th17极化是哮喘免疫病理的根基,但调控机制不明,可能与LncRNA有关。TUG1是高通量技术筛选获得差异表达于哮喘患儿单核细胞的LncRNA。预实验发现过表达LncRNA TUG1可以促进单核-巨噬细胞高表达B7-H3而诱导Th2/Th17细胞极化。B7-H3是Th2/Th17极化的关键分子,也是miR-29c-3p的直接靶基因。过表达或沉默miR-29c-3p可以下调或上调单核-巨噬细胞B7-H3表达。生物信息学预测LncRNA TUG1与miR-29c-3p存在结合位点。因此,推测LncRNA TUG1介导miR-29c-3p调控B7-H3表达促进Th2/Th17极化而在哮喘中起作用。鉴此,本项目通过体内外实验,阐明致敏原诱导LncRNA TUG1表达的作用机制以及LncRNA TUG1介导单核-巨噬细胞调控Th2/Th17极化的作用与机制,为哮喘的免疫干预提供新靶标。

项目摘要

Th2/Th17极化是哮喘免疫病理的根基,但调控机制不明。长链非编码RNA参与哮喘免疫病理,可能与Th细胞的极化有关。LncRNA TUG1是高通量技术筛选获得差异表达于哮喘患儿单核细胞的LncRNA。本项目聚焦LncRNA TUG1,通过体外研究证实LncRNA TUG1调控Th细胞的作用和机制。结果发现LncRNA TUG1和miR-29c共定位于胞浆,荧光素酶报告系统也证实LncRNA TUG1和miR-29c可以直接结合,提示LncRNA TUG1通过“海绵”作用调控miR-29c的表达。HDM可诱导巨噬细胞高表达LncRNA TUG1和B7-H3,而低表达miR-29c。既往课题组证实B7-H3是miR-29c的靶基因,且挽救策略也证实miR-29c可以靶向B7-H3进而调控GATA3和RORr-t的表达。下调LncRNA TUG1可以促进miR-29c高表达,进而抑制B7-H3表达,同时下调GATA3和RORr-t的表达。巨噬细胞中下调LncRNA TUG1,同时下调miR-29c,培养上清中的可溶性B7-H3表达增高,并与CD4+T细胞共培养,其GATA3和RORr-t表达增高。临床样本中LncRNA TUG1/miR-29c/B7-H3的表达和体外研究结果一致。鉴此,本项目通过体外实验,阐明了致敏原诱导LncRNA TUG1表达的作用以及巨噬细胞中LncRNA TUG1/ miR-29c/B7-H3轴调控Th2/Th17极化的作用与机制,为哮喘的免疫干预提供新靶标。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

视网膜母细胞瘤的治疗研究进展

视网膜母细胞瘤的治疗研究进展

DOI:
发表时间:2018
2

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
3

Simultaneous recovery of an infinite rough surface and the impedance from near-field data

Simultaneous recovery of an infinite rough surface and the impedance from near-field data

DOI:doi:10.1080/17415977.2018.1436172
发表时间:2018
4

当归补血汤促进异体移植的肌卫星细胞存活

当归补血汤促进异体移植的肌卫星细胞存活

DOI:
发表时间:2016
5

Image interpolation via collaging its non-local patches

Image interpolation via collaging its non-local patches

DOI:
发表时间:2016

陈正荣的其他基金

相似国自然基金

1

LncRNA TUG1在肺动脉平滑肌细胞增殖和肺血管重构中的作用及机制研究

批准号:81600034
批准年份:2016
负责人:王爽
学科分类:H0107
资助金额:15.00
项目类别:青年科学基金项目
2

B7-H3调控Th细胞分化及其在支气管哮喘免疫病理中的作用研究

批准号:81401296
批准年份:2014
负责人:陈正荣
学科分类:H1104
资助金额:23.00
项目类别:青年科学基金项目
3

嗜碱性粒细胞在日本血吸虫感染Th2免疫应答及免疫病理中的作用

批准号:81071382
批准年份:2010
负责人:陈小平
学科分类:H2203
资助金额:35.00
项目类别:面上项目
4

FceRI阳性细胞在日本血吸虫感染所致Th2免疫应答及免疫病理中的作用

批准号:81572021
批准年份:2015
负责人:陈小平
学科分类:H2203
资助金额:60.00
项目类别:面上项目